Acorda Therapeutics Cdt buy StockNews.com
Start price
29.04.23
/
50%
€0.41
Target price
29.04.24
-
Performance (%)
10.78%
End price
30.04.24
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 10.78%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acorda Therapeutics Cdt | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
In the thread Trading Acorda Therapeutics Cdt
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.58
31.05.23
31.05.23
-
31.05.24
31.05.24
-18.97%
01.06.24
01.06.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
07.05.23
07.05.23
-
07.05.24
07.05.24
-22.31%
08.05.24
08.05.24